Page 5,845«..1020..5,8445,8455,8465,847..5,8505,860..»

Enjoying The Ride: The Road To Living Well With Movement Disorders

Posted: Published on January 17th, 2013

(NAPSW)Innovative technology for the treatment of Parkinsons disease and other movement disorders was recently implanted for the 100,000th time worldwide, inspiring people like longtime fitness trainer Roy Roden to pursue previously impossible goals. Roden has always had an adventurous spirit, and the 55-year-old and his wife Lynn enjoy participating in many interesting outdoor activities together. This month, Roden and his wife embarked on their most challenging journey together yeta 4,500-mile cross-country bike ride to raise awareness and research funds for Parkinsons disease. Just a few months ago, these activities would have been unmanageable for Roden, who is one of the more than 1 million Americans living with Parkinsons. Diagnosed in 2008, he began experiencing difficulty over time with basic tasks, such as eating and getting dressed. Each day, he was taking 10 different medications, and their effectiveness was waning. It was crazyI was taking some medications purely to control the symptoms from other medications, Roden said. Last July, Roden made the decision with his neurologist and family to pursue Medtronic Deep Brain Stimulation (DBS) therapy, during which a small, pacemaker-like device sends electronic stimulation to a specific area of the brain that controls movement. The stimulation suppresses the unwanted motor … Continue reading

Posted in Parkinson's Treatment | Comments Off on Enjoying The Ride: The Road To Living Well With Movement Disorders

Westerham community's £70,000 fundraising drive for child…

Posted: Published on January 17th, 2013

JOHNNY Pantry has a broad smile and a typical five-year-old's cheeky sense of humour. He loves sausages, swimming and horse riding. drive: Five-year-old Johnny Pantry suffers from cerebral palsy, which means he can ride around on his trike but needs help to stand up or walk But without life-changing treatment in the United States, the bubbly Westerham youngster who is battling cerebral palsy faces a future of surgery, pain and life in a wheelchair. Now, in a major series of fundraising drives across the district, family, friends and neighbours are trying to find the 70,000 needed for his treatment in America and the subsequent two years' intensive physiotherapy he will need back in the UK. Available every Thursday on selected cocktails Terms: Excluding 14/02/13 Valid until: Thursday, February 28 2013 In just two months, supporters have raised a staggering 20,000 through events as varied as golf days organised by the Grasshopper on the Green, Westerham, a sponsored jog by pupils of Amherst School, Riverhead, and a cake sale at St Mary's Church, Westerham. A mystery donor has also given 1,000 to the cause. See the article here: Westerham community's £70,000 fundraising drive for child... … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Westerham community's £70,000 fundraising drive for child…

Sevenoaks Chronicle published Westerham community's £70,000 fundraising drive for child…

Posted: Published on January 17th, 2013

JOHNNY Pantry has a broad smile and a typical five-year-old's cheeky sense of humour. He loves sausages, swimming and horse riding. drive: Five-year-old Johnny Pantry suffers from cerebral palsy, which means he can ride around on his trike but needs help to stand up or walk But without life-changing treatment in the United States, the bubbly Westerham youngster who is battling cerebral palsy faces a future of surgery, pain and life in a wheelchair. Now, in a major series of fundraising drives across the district, family, friends and neighbours are trying to find the 70,000 needed for his treatment in America and the subsequent two years' intensive physiotherapy he will need back in the UK. Available every Thursday on selected cocktails Terms: Excluding 14/02/13 Valid until: Thursday, February 28 2013 In just two months, supporters have raised a staggering 20,000 through events as varied as golf days organised by the Grasshopper on the Green, Westerham, a sponsored jog by pupils of Amherst School, Riverhead, and a cake sale at St Mary's Church, Westerham. A mystery donor has also given 1,000 to the cause. Here is the original post: Sevenoaks Chronicle published Westerham community's £70,000 fundraising drive for child... … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Sevenoaks Chronicle published Westerham community's £70,000 fundraising drive for child…

Sevenoaks Chronicle published 'We'll prevent Johnny facing future of pain'

Posted: Published on January 17th, 2013

JOHNNY Pantry has a broad smile and a typical five-year-old's cheeky sense of humour. He loves sausages, swimming and horse riding. drive: Five-year-old Johnny Pantry suffers from cerebral palsy, which means he can ride around on his trike but needs help to stand up or walk But without life-changing treatment in the United States, the bubbly Westerham youngster who is battling cerebral palsy faces a future of surgery, pain and life in a wheelchair. Now, in a major series of fundraising drives across the district, family, friends and neighbours are trying to find the 70,000 needed for his treatment in America and the subsequent two years' intensive physiotherapy he will need back in the UK. Available every Thursday on selected cocktails Terms: Excluding 14/02/13 Valid until: Thursday, February 28 2013 In just two months, supporters have raised a staggering 20,000 through events as varied as golf days organised by the Grasshopper on the Green, Westerham, a sponsored jog by pupils of Amherst School, Riverhead, and a cake sale at St Mary's Church, Westerham. A mystery donor has also given 1,000 to the cause. Read the rest here: Sevenoaks Chronicle published 'We'll prevent Johnny facing future of pain' … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Sevenoaks Chronicle published 'We'll prevent Johnny facing future of pain'

Arizona project to help traumatic brain injury patients

Posted: Published on January 17th, 2013

By ALISON DORF Published January 17, 2013 at 2:59am Updated January 17, 2013 at 2:59am A statewide collaboration is furthering the treatment of traumatic brain injuries within Arizona. The National Institutes of Health chose Arizona as the only state to evaluate the national standards for pre-hospital emergency care of traumatic brain injury, according to an Arizona Department of Health Services news release. Some attribute this success in treating severe brain injuries to the Excellence in Pre-hospital Injury Care, or EPIC, program. The UA College of Medicine is currently involved with EPIC, which is the only project of its kind in the country. It is a major collaboration between the Arizona Department of Health Services, the UA, Arizona Fire Departments and EMS agencies. Through EPIC, it is possible to track how its guidelines are helping patients by collecting data from paramedics and EMTs, and linking it to the Arizona State Trauma Registry. It is then possible to determine different scenarios for patients, including survival, length of stay in the hospital and cost, according to Dr. Ben Bobrow, medical director at the Bureau of EMS and Trauma System and a professor of emergency medicine at the UA College of Medicine on the … Continue reading

Posted in Brain Injury Treatment | Comments Off on Arizona project to help traumatic brain injury patients

Research reveals exactly how the human brain adapts to injury

Posted: Published on January 17th, 2013

Jan. 16, 2013 For the first time, scientists at Carnegie Mellon University's Center for Cognitive Brain Imaging (CCBI) have used a new combination of neural imaging methods to discover exactly how the human brain adapts to injury. The research, published in Cerebral Cortex, shows that when one brain area loses functionality, a "back-up" team of secondary brain areas immediately activates, replacing not only the unavailable area but also its confederates. "The human brain has a remarkable ability to adapt to various types of trauma, such as traumatic brain injury and stroke, making it possible for people to continue functioning after key brain areas have been damaged," said Marcel Just, the D. O. Hebb Professor of Psychology at CMU and CCBI director. "It is now clear how the brain can naturally rebound from injuries and gives us indications of how individuals can train their brains to be prepared for easier recovery. The secret is to develop alternative thinking styles, the way a switch-hitter develops alternative batting styles. Then, if a muscle in one arm is injured, they can use the batting style that relies more on the uninjured arm." For the study, Just, Robert Mason, senior research psychologist at CMU, and … Continue reading

Posted in Brain Injury Treatment | Comments Off on Research reveals exactly how the human brain adapts to injury

InfraScan Receives FDA Approval of Next Generation, Noninvasive Handheld Brain Hematoma Detector

Posted: Published on January 17th, 2013

PHILADELPHIA--(BUSINESS WIRE)-- InfraScan, a medical device company specializing in brain injury diagnostic products, announced today that it has obtained U.S. Food and Drug Administration approval to market the Infrascanner Model 2000, a noninvasive handheld brain hematoma detector. The Infrascanner Model 2000 is a handheld device with a disposable patient interface that uses Near-Infrared (NIR) technology to detect intracranial bleeding, identifying those patients who would most benefit from immediate referral to a CT scan and neurosurgical intervention. FDA approval in the U.S. allows InfraScan to offer an industry first, powerful tool for use by civilian and military medical professionals to quickly triage head trauma patients, said Baruch Ben Dor, President and CEO of InfraScan, Inc. Shortening the time to treatment through effective detection of intracranial bleeding can mean preserving brain function in a patient and even saving lives. The Infrascanner Model 2000 was developed in partnership with U.S. Navy and Marine Corps. The Model 2000 features upgrades that meet the specifications of the U.S. Marine Corps and is a ruggedized, integrated, user-friendly unit. Before the Infrascanner, first responders had to rely on imprecise methods to detect brain bleeds in patients, potentially delaying treatment, said Dr. Joseph Maroon, Professor and Vice Chairman … Continue reading

Posted in Brain Injury Treatment | Comments Off on InfraScan Receives FDA Approval of Next Generation, Noninvasive Handheld Brain Hematoma Detector

Elan Corporation PLC UK Regulatory Announcement: BIOGEN IDEC AND ELAN SUBMIT APPLICATIONS FOR FIRST-LINE USE OF …

Posted: Published on January 17th, 2013

DUBLIN--(BUSINESS WIRE)-- TYSABRI is an important treatment option for thousands of people living with MS BIOGEN IDEC AND ELAN SUBMIT APPLICATIONS FOR FIRST-LINE USE OF TYSABRI IN ANTI-JCV ANTIBODY NEGATIVE PATIENTS WITH MS - Marketing Applications Supported by Risk Stratification Data - Weston, Mass. & Dublin January 16, 2013 Today Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced that they have submitted applications to the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) requesting updates to the TYSABRI (natalizumab) labels. The applications request an expanded indication that would include first-line use for people living with certain relapsing forms of multiple sclerosis (MS) who have tested negative for antibodies to the JC virus (JCV). A formal assessment of both applications is ongoing. These submissions are supported by risk stratification data and a risk algorithm that enables physicians and individuals living with MS to make informed decisions when considering treatment with TYSABRI. If approved, a first-line label will allow all appropriate anti-JCV antibody negative patients to consider TYSABRI early in the course of treatment, regardless of the level of disease activity or prior treatment history. TYSABRI is a highly efficacious treatment that has been shown to … Continue reading

Posted in MS Treatment | Comments Off on Elan Corporation PLC UK Regulatory Announcement: BIOGEN IDEC AND ELAN SUBMIT APPLICATIONS FOR FIRST-LINE USE OF …

UPDATE 1-Biogen, Elan seek okay for first-line Tysabri use in MS

Posted: Published on January 17th, 2013

(Adds analyst comment, background) * Firms hope new test will pave way for wider use of drug * Tysabri highly effective but PML risk has curbed uptake LONDON, Jan 16 (Reuters) - Biogen Idec (NasdaqGS: BIIB - news) and Elan have filed for approval to sell their drug Tysabri as a first-line treatment for multiple sclerosis, a move that could boost sales of the drug. Demand for Tysabri has been curtailed due to concerns over its association with a potentially fatal infection known as progressive multifocal leukoencephalopathy, or PML, which is caused by the JC virus. Now (Other OTC: NWPN - news) , however, there is a test for the virus to predict if patients are at risk of developing PML, opening the possibility that Tysabri could be used more widely and at an earlier stage of treatment. Biogen and Elan said on Wednesday they had submitted applications to the U.S. Food and Drug Administration and the European Medicines Agency seeking approval for first-line use in patients with relapsing forms of multiple sclerosis (MS) who have tested negative for antibodies to the JC virus. The JC virus is generally harmless, but in people with weakened immune systems, such as those … Continue reading

Posted in MS Treatment | Comments Off on UPDATE 1-Biogen, Elan seek okay for first-line Tysabri use in MS

Elan and Biogen eye MS drug sales boost

Posted: Published on January 17th, 2013

Elan and Biogen Idec hope Tysabri would be used more widely and at earlier stage of treatment for MS Elan and Biogen Idec have filed for approval to sell their drug Tysabri as a first-line treatment for multiple sclerosis. The move that could boost sales of the drug. Demand for Tysabri has been curtailed due to concerns over its association with a potentially fatal infection known as progressive multifocal leukoencephalopathy, or PML, which is caused by the JC virus. Now, however, there is a test for the virus to predict if patients are at risk of developing PML. This opens the possibility that Tysabri could be used more widely and at an earlier stage of treatment. Elan and Biogen said today they had submitted applications to the US Food and Drug Administration and the European Medicines Agency seeking approval for first-line use in patients with relapsing forms of multiple sclerosis (MS) who have tested negative for antibodies to the JC virus. The JC virus is generally harmless, but in people with weakened immune systems, such as those using immune system-suppressing drugs like Tysabri, it can lead to an increased chance of developing PML. Tysabri use is currently limited to between … Continue reading

Posted in MS Treatment | Comments Off on Elan and Biogen eye MS drug sales boost

Page 5,845«..1020..5,8445,8455,8465,847..5,8505,860..»